India on Monday opened the famous Mughal-era monument Taj Mahal to tourists with COVID-19 safety guidelines.
The country has started opening public spaces under the fourth round of easing the restrictions called Unlock-4. As a result, the 17th-century white marble mausoleum built by Mughal emperor Shah Jahan in the city of Agra opened its doors to tourists. It usually draws seven million visitors a year.
The world-renowned monument remained closed for the last six months due to the pandemic, confirmed the Archaeological Survey of India.
“Only 5,000 tourists will be allowed each day. Masks are mandatory to enter the monument and strict restrictions on group photography,” said Vasant Kumar Swarnkar, superintending archaeologist of the Archaeological Survey of India (Agra circle), in a video interview to a local media channel, Mojo Story.
Meanwhile, India recorded 86,961 new COVID-19 cases and 1,130 deaths in the last 24 hours, revealed data from the Health Ministry.
The confirmed cases toll now stands at 5.4 million, including 87,882 deaths with a 1.6% mortality rate.
Close to 4.4 million patients have recovered from the infection, pushing the recovery rate to 80.11%. The total number of cases in the country include one million active cases. The recovered patients exceed active cases by 3.3 million.
As per the Health Ministry data, 93,356 patients recovered from the infection in the last 24 hours, thus the recoveries exceed the daily cases for a third consecutive day.
Of the new confirmed cases, 76% are concentrated in only 10 states. These states account for 86% of the new fatalities.
The western state of Maharashtra reported more than 20,000 new cases and 455 deaths, taking the total cases past 1.2 million and the death toll to 32,671. The southern state of Andhra Pradesh has added 8,000 new cases, taking its toll to 625,514 and the death toll to 5,359.
“No significant mutation in SARS-CoV-2 in India. ICMR [Indian Council of Medical Research] is actively exploring the saliva-based test for COVID-19. Atmanirbhar Bharat (self-reliant India), underlines government’s commitment for increased investments in public health and other health reforms to prepare India for future pandemics,” said Harsh Vardhan, Indian health minister, during interaction with social media users on Sunday.
He dispelled doubts raised over the failure of one vaccine in clinical trials and said: “Trials are continuing only after expert committee reappraisal.” He confirmed that over four coronavirus vaccines are in advanced stages of pre-clinical trial in India.
On Monday, the Drug Controller General of India also approved the commercial launch of a new paper-based test strip, called “Feluda,” to detect COVID-19 in less than 30 minutes. It is developed by the Council of Scientific and Industrial Research.
Copyright 2021 Anadolu Agency. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.